← All Sponsors

SPONSOR

BioEclipse Therapeutics

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: Solid Tumor, Adult Triple Negative Breast Cancer Colorectal Cancer Hepatocellular Carcinoma Osteosarcoma Epithelial Ovarian Cancer Gastric Cancer Non-small Cell Lung Cancer Malignant Melanoma

NCT04282044 Phase 1

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Solid Tumor, Adult